Biosimilars business review.
Espicom Business Intelligence,issuing body.
Description based on: issue 27 (June 2014); title from PDF caption.
Pharmaceutical industry
Biologicals
Drug development
Biosimilars business review
Current Copyright Fee: GBP100.00
Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.